Search research articles
Contact Us
Filters
Showing results (61-70 of 102) with videos related to
Page
of 11
Sort By:
Annals of the New York Academy of Sciences
|
November 30, 1993
High-intensity chemotherapy with hematopoietic support in breast cancer
J Crown, L Vahdat, D Fennelly, et al.
Blood
|
September 15, 1991
A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer
J Crown, A Jakubowski, N Kemeny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1993
Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer
J Crown, A Kritz, L Vahdat, et al.
Anticancer Research
|
April 13, 2001
Doxorubicin followed by docetaxel versus docetaxel followed by doxorubicin in the adjuvant treatment of node positive breast cancer: results of a feasibility study
F Cardoso, A F Ferreira Filho, J Crown, et al.
Bone Marrow Transplantation
|
April 5, 2005
Ancestim associated with Filgrastim and/or chemotherapy can improve blood progenitor yields in patients who previously failed mobilisation
A Mijovic, N Russell, R E Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1992
Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation
S Gulati, J Yahalom, L Acaba, et al.
Anticancer Research
|
August 19, 2007
MDR1/P-glycoprotein and MRP-1 drug efflux pumps in pancreatic carcinoma
L O'Driscoll, N Walsh, A Larkin, et al.
Cancer Research
|
December 1, 1994
Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: a phase I trial
D Fennelly, C Wasserheit, J Schneider, et al.
Cancer
|
February 15, 1993
Phase II trial of carboplatin and etoposide in metastatic breast cancer
J Crown, T Hakes, B Reichman, et al.
British Journal of Cancer
|
December 22, 2004
Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer
B Ryan, N O'Donovan, B Browne, et al.
Page
of 11
Search research articles
Search
Showing results (61-70 of 102) with videos related to
Sort By:
Page
of 11
Annals of the New York Academy of Sciences
|
November 30, 1993
High-intensity chemotherapy with hematopoietic support in breast cancer
J Crown, L Vahdat, D Fennelly, et al.
Blood
|
September 15, 1991
A phase I trial of recombinant human interleukin-1 beta alone and in combination with myelosuppressive doses of 5-fluorouracil in patients with gastrointestinal cancer
J Crown, A Jakubowski, N Kemeny, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1993
Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer
J Crown, A Kritz, L Vahdat, et al.
Anticancer Research
|
April 13, 2001
Doxorubicin followed by docetaxel versus docetaxel followed by doxorubicin in the adjuvant treatment of node positive breast cancer: results of a feasibility study
F Cardoso, A F Ferreira Filho, J Crown, et al.
Bone Marrow Transplantation
|
April 5, 2005
Ancestim associated with Filgrastim and/or chemotherapy can improve blood progenitor yields in patients who previously failed mobilisation
A Mijovic, N Russell, R E Clark, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1992
Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation
S Gulati, J Yahalom, L Acaba, et al.
Anticancer Research
|
August 19, 2007
MDR1/P-glycoprotein and MRP-1 drug efflux pumps in pancreatic carcinoma
L O'Driscoll, N Walsh, A Larkin, et al.
Cancer Research
|
December 1, 1994
Simultaneous dose escalation and schedule intensification of carboplatin-based chemotherapy using peripheral blood progenitor cells and filgrastim: a phase I trial
D Fennelly, C Wasserheit, J Schneider, et al.
Cancer
|
February 15, 1993
Phase II trial of carboplatin and etoposide in metastatic breast cancer
J Crown, T Hakes, B Reichman, et al.
British Journal of Cancer
|
December 22, 2004
Expression of survivin and its splice variants survivin-2B and survivin-DeltaEx3 in breast cancer
B Ryan, N O'Donovan, B Browne, et al.
Page
of 11